Judge Extends Block to Huge Cuts in National Institutes of Health Research Funding
Healthcare organizations and 22 states have sued to stop the cuts. The case is expected to reach the Supreme Court.
Judge Extends Temporary Block to Huge Cuts in National Institutes of Health Research Funding
A judge on Friday extended a temporary block of the Trump Administration’s drastic cuts in medical research funding.
BMJ18h
NICE to offer epilepsy treatment after discounted price is agreed
The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...
Most say health care costs, inflation biggest issue facing Americans: Pew
A new survey from Pew Research Center has found that most Americans think inflation, health care cost, and the federal budget ...
The Pharma Letter20h
NICE recommends Breyanzi for B-cell lymphomas
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...
Medscape21h
NICE Approves Fenfluramine for Lennox-Gastaut Syndrome
The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.
NICE green lights two blood cancer therapies for NHS use
BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
openaccessgovernment23h
New NHS treatment offers hope for children with Lennox–Gastaut syndrome
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...